Congratulations to Associate Prof. Dr. Haslina Ahmad and her colleagues for their latest publication in Pharmaceutics. This paper describes the mesoporous silica nanoparticles (MSNs) as an ideal drug delivery agent that able to sustainably release Ru-PIP (a potential anticancer drug) by diffusion in a prolonged treatment period. Find out more at https://www.mdpi.com/1999-4923/13/2/150.
Date of Input: 08/02/2021 | Updated: 08/02/2021 | azah